How Well Do Results From Randomized Clinical Trials and/or Recommendations for Implantable Cardioverter-Defibrillator Programming Diffuse Into Clinical Practice?
guideline adherence
guidelines
implantable cardioverter‐defibrillator
programming
remote monitoring
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
05 02 2019
05 02 2019
Historique:
entrez:
5
2
2019
pubmed:
5
2
2019
medline:
25
2
2020
Statut:
ppublish
Résumé
Background Inappropriate implantable cardioverter-defibrillator programming can be detrimental. Whether trials/recommendations informing best implantable cardioverter-defibrillator programming (high-rate cutoff and/or extended duration of detection) influence practice is unknown. Methods and Results We measured reaction to publication of MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy; 2012) and the Consensus Statement (2015) providing generic programming parameters, in a national cohort of implantable cardioverter-defibrillator recipients, using the ALTITUDE database (Boston Scientific). Yearly changes in programmed parameters to either trial-specified or class 1 recommended parameters (≥185 beats per minute or delay ≥6 seconds) were assessed in parallel. From 2008 to 2017, 232 982 patients (aged 67±13 years; 28% women) were analyzed. Prevalence of MADIT- RIT -specific settings before publication was <1%, increasing to 13.6% in the year following. Thereafter, this increased by <6% over 5 years. Among preexisting implants (91 171), most patients (58 739 [64.4%]) underwent at least 1 in-person device reprogramming after trial publication, but <2% were reprogrammed to MADIT - RIT settings. Notably, prevalence of programming to ≥185 beats per minute or delay ≥6 seconds was increased by MADIT - RIT (57.4% in 2013 versus 40.2% at baseline), but the following publication of recommendations had minor incremental effect (73.2% in 2016 versus 70.8% in 2015). High-rate cutoff programming was favored almost 2-fold compared with extended duration throughout the test period. Practice changes demonstrated large interhospital and interstate variations. Conclusions Trial publication had an immediate effect during 1 year postpublication, but absolute penetration was low, and amplified little with time. Consensus recommendations had a negligible effect. However, generic programming was exercised more widely, and increased after trial publication, but not following recommendations.
Identifiants
pubmed: 30712432
doi: 10.1161/JAHA.117.007392
pmc: PMC6405582
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e007392Références
N Engl J Med. 2012 Dec 13;367(24):2275-83
pubmed: 23131066
JAMA. 2015 Jul 28;314(4):337-8
pubmed: 26219044
Heart Rhythm. 2009 Dec;6(12):1727-34
pubmed: 19959119
Eur Heart J. 2013 Feb;34(8):605-14
pubmed: 23242192
Europace. 2013 Jun;15 Suppl 1:i11-i13
pubmed: 23737222
Circulation. 2013 Nov 26;128(22):2447-60
pubmed: 24166574
Stroke. 2012 Dec;43(12):3442-53
pubmed: 22858728
Circulation. 2010 Jul 27;122(4):325-32
pubmed: 20625110
Heart Rhythm. 2015 Jul;12(7):e69-100
pubmed: 25981148
Europace. 2013 Jun;15 Suppl 1:i69-i71
pubmed: 23737236
Circulation. 2013 Nov 26;128(22):2372-83
pubmed: 24043302
Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2):
pubmed: 28196927
Circulation. 2010 Dec 7;122(23):2359-67
pubmed: 21098452
Circ Heart Fail. 2008 Jul;1(2):98-106
pubmed: 19808279
J Am Coll Cardiol. 2015 Jun 23;65(24):2601-2610
pubmed: 25983008
Circ Heart Fail. 2015 May;8(3):473-80
pubmed: 25747700
JACC Clin Electrophysiol. 2017 Nov;3(11):1275-1282
pubmed: 29759624
Heart Rhythm. 2015 Mar;12(3):545-553
pubmed: 25460168
Heart Rhythm. 2016 Feb;13(2):e50-86
pubmed: 26607062
Eur Heart J. 2014 May 21;35(20):1345-52
pubmed: 24595864
JAMA. 2013 May 8;309(18):1903-11
pubmed: 23652522
J Am Coll Cardiol. 2013 Nov 19;62(21):1931-1947
pubmed: 24036027
Circulation. 2016 Jan 19;133(3):273-81
pubmed: 26635400
J Am Heart Assoc. 2019 Feb 5;8(3):e007392
pubmed: 30712432
Circ Arrhythm Electrophysiol. 2017 Sep;10(9):
pubmed: 28916511
Circulation. 2014 Jul 22;130(4):308-14
pubmed: 24838360
J Am Coll Cardiol. 2012 Oct 16;60(16):1484-8
pubmed: 22999725
J Am Coll Cardiol. 2018 Jul 24;72(4):351-366
pubmed: 30025570
Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1):e000022
pubmed: 27993943